Jade Medical Limited

POWER SEARCH PRICING

SOLUTIONS

jade medical limited Company Information

Live

MatureMicroHealthy

Company Number

02572145

Next Accounts

Dec 2025

Industry

Other human health activities

Directors

John Gray

Alison Gray

Shareholders

mr john holm gray

mrs alison balfour gray

Group Structure

View All

Contact

Registered Address

13 holmlea road, goring, reading, RG8 9EX

Website

www.jade-medical.co.uk

jade medical limited Estimated Valuation

£198.2k

Pomanda estimates the enterprise value of JADE MEDICAL LIMITED at £198.2k based on a Turnover of £346k and 0.57x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Jade Medical Limited is a live company located in reading, RG8 9EX with a Companies House number of 02572145. It operates in the other human health activities sector, SIC Code 86900. Founded in January 1991, it's largest shareholder is mr john holm gray with a 50% stake. Jade Medical Limited is a mature, micro sized company, Pomanda has estimated its turnover at £346k with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Jade Medical Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

3 Strong

3 Regular

6 Weak

Size

annual sales of £346k, make it smaller than the average company (£683.1k)

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (7.2%)

EXPORT

Jade Medical Limited's latest turnover from March 2024 is estimated at £346 thousand and the company has net assets of £2.4 thousand. According to their latest financial statements, Jade Medical Limited has 5 employees and maintains cash reserves of £59.5 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	346,041	349,393	240,625	236,922	450,801	381,453	317,572	329,045	284,105	624,770	960,707	891,952	868,540	870,976	671,048
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	216,500	222,336	154,799	158,848	292,551	251,542	204,168	204,150	177,436	389,190	595,517	538,188	500,090	489,754	380,777
Gross Profit	129,541	127,056	85,825	78,074	158,249	129,911	113,404	124,895	106,668	235,580	365,190	353,764	368,450	381,222	290,271
Admin Expenses	153,242	109,305	92,660	118,600	125,355	135,191	104,018	111,417	133,978	239,310	362,055	358,094	346,853	361,699	270,795
Operating Profit	-23,701	17,751	-6,835	-40,526	32,894	-5,280	9,386	13,478	-27,310	-3,730	3,135	-4,330	21,597	19,523	19,476
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	3,406	2,832	436	67	63	364	255	114	188	242	283	230	190	207	117
Pre-Tax Profit	-20,295	20,583	-6,399	-40,459	32,957	-4,916	9,641	13,591	-27,122	-3,488	3,418	-4,100	21,788	19,729	19,593
Tax	0	-3,911	0	0	-6,262	0	-1,832	-2,718	0	0	-786	0	-5,665	-5,524	-5,486
Profit After Tax	-20,295	16,672	-6,399	-40,459	26,695	-4,916	7,809	10,873	-27,122	-3,488	2,632	-4,100	16,123	14,205	14,107
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-20,295	16,672	-6,399	-40,459	26,695	-4,916	7,809	10,873	-27,122	-3,488	2,632	-4,100	16,123	14,205	14,107
Employee Costs	129,790	123,064	117,086	114,175	111,601	109,430	106,057	104,870	105,620	371,023	562,456	537,930	511,610	501,449	386,897
Number Of Employees	5	5	5	5	5	5	5	5	5	17	26	25	24	24	19
EBITDA*	-23,416	18,132	-5,835	-39,528	33,714	-4,091	10,624	14,335	-24,726	5,694	11,540	3,797	28,912	23,132	24,182

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	859	1,144	1,525	2,525	2,028	1,899	3,088	1,725	969	25,613	35,037	19,307	25,309	12,650	16,259
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	859	1,144	1,525	2,525	2,028	1,899	3,088	1,725	969	25,613	35,037	19,307	25,309	12,650	16,259
Stock & work in progress	6,562	7,927	7,910	29,290	21,321	22,440	15,176	12,841	6,406	13,210	14,875	6,517	11,530	11,032	17,630
Trade Debtors	36,065	42,814	22,547	15,802	56,255	48,389	40,787	43,011	35,051	29,238	37,611	43,353	45,676	51,665	32,780
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	100	100	100	100	100	100	100	100	4,100	0	0	0	0	0	0
Cash	59,511	70,241	63,035	53,350	80,446	46,068	50,952	51,006	39,866	35,389	61,516	51,582	40,475	35,688	46,922
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	102,238	121,082	93,592	98,542	158,122	116,997	107,015	106,958	85,423	77,837	114,002	101,452	97,681	98,385	97,332
total assets	103,097	122,226	95,117	101,067	160,150	118,896	110,103	108,683	86,392	103,450	149,039	120,759	122,990	111,035	113,591
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	21,214	18,897	7,685	11,318	22,989	14,882	9,752	8,346	5,498	63,871	105,972	80,324	78,455	82,623	99,384
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	79,446	80,597	81,372	77,290	84,243	77,791	69,212	77,007	68,437	0	0	0	0	0	0
total current liabilities	100,660	99,494	89,057	88,608	107,232	92,673	78,964	85,353	73,935	63,871	105,972	80,324	78,455	82,623	99,384
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	100,660	99,494	89,057	88,608	107,232	92,673	78,964	85,353	73,935	63,871	105,972	80,324	78,455	82,623	99,384
net assets	2,437	22,732	6,060	12,459	52,918	26,223	31,139	23,330	12,457	39,579	43,067	40,435	44,535	28,412	14,207
total shareholders funds	2,437	22,732	6,060	12,459	52,918	26,223	31,139	23,330	12,457	39,579	43,067	40,435	44,535	28,412	14,207

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-23,701	17,751	-6,835	-40,526	32,894	-5,280	9,386	13,478	-27,310	-3,730	3,135	-4,330	21,597	19,523	19,476
Depreciation	285	381	1,000	998	820	1,189	1,238	857	2,584	9,424	8,405	8,127	7,315	3,609	4,706
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	-3,911	0	0	-6,262	0	-1,832	-2,718	0	0	-786	0	-5,665	-5,524	-5,486
Stock	-1,365	17	-21,380	7,969	-1,119	7,264	2,335	6,435	-6,804	-1,665	8,358	-5,013	498	-6,598	17,630
Debtors	-6,749	20,267	6,745	-40,453	7,866	7,602	-2,224	3,960	9,913	-8,373	-5,742	-2,323	-5,989	18,885	32,780
Creditors	2,317	11,212	-3,633	-11,671	8,107	5,130	1,406	2,848	-58,373	-42,101	25,648	1,869	-4,168	-16,761	99,384
Accruals and Deferred Income	-1,151	-775	4,082	-6,953	6,452	8,579	-7,795	8,570	68,437	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-14,136	4,374	9,249	-25,668	35,264	-5,248	2,292	12,640	-17,771	-26,369	33,786	13,002	24,570	-11,440	67,670
Investing Activities
capital expenditure	0	0	0	-1,495	-949	0	-2,601	-1,613	22,060	0	-24,135	-2,125	-19,974	0	-20,965
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	0	0	-1,495	-949	0	-2,601	-1,613	22,060	0	-24,135	-2,125	-19,974	0	-20,965
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	100
interest	3,406	2,832	436	67	63	364	255	114	188	242	283	230	190	207	117
cash flow from financing	3,406	2,832	436	67	63	364	255	114	188	242	283	230	190	207	217
cash and cash equivalents
cash	-10,730	7,206	9,685	-27,096	34,378	-4,884	-54	11,140	4,477	-26,127	9,934	11,107	4,787	-11,234	46,922
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-10,730	7,206	9,685	-27,096	34,378	-4,884	-54	11,140	4,477	-26,127	9,934	11,107	4,787	-11,234	46,922

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for jade medical limited. Get real-time insights into jade medical limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for jade medical limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in RG8 area or any other competitors across 12 key performance metrics.

JADE MEDICAL LIMITED group structure

Jade Medical Limited has no subsidiary companies.

Ultimate parent company

JADE MEDICAL LIMITED

02572145

JADE MEDICAL LIMITED Shareholders

mr john holm gray	50%
mrs alison balfour gray	50%

Jade Medical Limited currently has 2 directors. The longest serving directors include Mr John Gray (Jan 1991) and Ms Alison Gray (Dec 2004).

officer	country	age	start	end	role
Mr John Gray		77 years	Jan 1991	-	Director
Ms Alison Gray		78 years	Dec 2004	-	Director

P&L

March 2024

turnover

346k

-1%

operating profit

-23.7k

gross margin

37.5%

+2.94%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

2.4k

-0.89%

total assets

103.1k

-0.16%

cash

59.5k

-0.15%

net assets

Total assets minus all liabilities

Similar Companies

omega regulatory consultancy limited

2.5

berkshire independent psychology services ltd

pro medical europe ltd

2.5

deeba anandan ltd

dnactiv8 ltd

company number

02572145

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

January 1991

ultimate parent company

None

previous names

grenford limited (January 1991)

address

13 holmlea road, goring, reading, RG8 9EX

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to jade medical limited. Currently there are 0 open charges and 1 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for JADE MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.

jade medical limited Company Information

jade medical limited Estimated Valuation

jade medical limited Estimated Valuation

jade medical limited Estimated Valuation

Jade Medical Limited Overview

Jade Medical Limited Health Check

JADE MEDICAL LIMITED financials

jade medical limited Credit Report and Business Information

Jade Medical Limited Competitor Analysis

jade medical limited Ownership

jade medical limited directors

jade medical limited company details

jade medical limited Charges & Mortgages

jade medical limited Capital Raised & Share Issues BETA

jade medical limited Companies House Filings - See Documents